Your browser doesn't support javascript.
loading
Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings.
Morita, Atsuho; Namkoong, Ho; Yagi, Kazuma; Asakura, Takanori; Hosoya, Makoto; Tanaka, Hiromu; Lee, Ho; Ogawa, Takunori; Kusumoto, Tatsuya; Azekawa, Shuhei; Nakagawara, Kensuke; Kamata, Hirofumi; Ishii, Makoto; Fukunaga, Koichi; Ozawa, Hiroyuki; Hasegawa, Naoki.
Afiliación
  • Morita A; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Namkoong H; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
  • Yagi K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Asakura T; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Hosoya M; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Tanaka H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Lee H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ogawa T; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kusumoto T; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Azekawa S; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nakagawara K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kamata H; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ishii M; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Fukunaga K; Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Ozawa H; Department of Otorhinolaryngology, Head and Neck Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Infect Drug Resist ; 15: 4001-4011, 2022.
Article en En | MEDLINE | ID: mdl-35924016
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Infect Drug Resist Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Infect Drug Resist Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Nueva Zelanda